Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Differential Gene Expression of ASUN, NEMF, PTPRC and DHX29: Candidate Biomarkers for the Diagnosis of Active and Latent Tuberculosis

Author(s): Setareh Mamishi, Babak Pourakbari , Reihaneh Hosseinpour Sadeghi , Majid Marjani and Shima Mahmoudi*

Volume 21, Issue 2, 2021

Published on: 13 March, 2020

Page: [268 - 273] Pages: 6

DOI: 10.2174/1871526520666200313144951

Price: $65

Abstract

Introduction: Tuberculosis (TB) remains one of the most important infectious causes of death throughout the world. A wide range of technologies have been used for the diagnosis of TB. However, current diagnostic tests are inadequate. The aim of this study was to evaluate the expression of four genes, namely ASUN, NEMF, PTPRC and DHX29 as candidate biomarkers for the diagnosis of Latent tuberculosis infection (LTBI) and active TB and discrimination of active TB and LTBI.

Materials and Methods: The expression of the mentioned four genes as well as ACTB as a housekeeping gene was evaluated by real-time PCR. Receiver operating characteristic (ROC) curve analysis was conducted to assess the specificity and sensitivity of each validated biomarker.

Results: Our results showed that the expression of theASUN gene could discriminate between active TB cases and healthy BCG vaccinated volunteers with an AUC value of 0.76, combing with a sensitivity of 68% and a specificity of 67%. It should be noted that the PTPRC gene also has the potential for the diagnosis of active TB with an AUC value of 0.67 and a sensitivity of 64.5% and a specificity of 70%. The curve revealed that cases with LTBI could be distinguished from healthy BCG vaccinated volunteers according to their expression of the ASUN gene with an AUC value of 0.81. The cut-off value for diagnosing was 11, with a sensitivity of 73% and a specificity of 79%. Moreover, the expression of the NEMF gene might be considered as a diagnostic tool for the diagnosis of LTBI. The analysis showed an AUC value of 0.75. The highest sensitivity (60%) and specificity (81%) were obtained with a cut off value of 12.

Conclusion: According to our results, the expression of ASUN and NEMF genes might be considered as a diagnostic tool for the diagnosis of LTBI. Our study showed that the expression of ASUN and PTPRC was obviously higher in active TB patients than those in healthy BCG vaccinated controls. On the other hand, DHX29 and PTPRC genes might be helpful in differentiating active TB and LTBI. However, our findings deserve further validation in larger studies.

Keywords: Tuberculosis, LTBI, gene expression, biomarker, ASUN, NEMF, PTPRC, DHX29.

Graphical Abstract

[1]
Turetz, M.L.; Ma, K.C. Diagnosis and management of latent tuberculosis. Curr. Opin. Infect. Dis., 2016, 29(2), 205-211.
[http://dx.doi.org/10.1097/QCO.0000000000000253] [PMID: 26836374]
[2]
Frahm, M.; Goswami, N.D.; Owzar, K.; Hecker, E.; Mosher, A.; Cadogan, E.; Nahid, P.; Ferrari, G.; Stout, J.E. Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis (Edinb.), 2011, 91(3), 250-256.
[http://dx.doi.org/10.1016/j.tube.2011.02.006] [PMID: 21393062]
[3]
Keshavarz Valian, S.; Mahmoudi, S.; Pourakbari, B.; Abdolsalehi, M.R.; Eshaghi, H.; Mamishi, S. Screening of healthcare workers for latent tuberculosis infection in the low tuberculosis burden country: QuantiFERON-TB gold in tube test or tuberculin skin test? Arch. Environ. Occup. Health, 2019, 74(3), 109-114.
[http://dx.doi.org/10.1080/19338244.2017.1394254] [PMID: 30516445]
[4]
Barry, C.E., III; Boshoff, H.I.; Dartois, V.; Dick, T.; Ehrt, S.; Flynn, J.; Schnappinger, D.; Wilkinson, R.J.; Young, D. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol., 2009, 7(12), 845-855.
[http://dx.doi.org/10.1038/nrmicro2236] [PMID: 19855401]
[5]
Chegou, N.N.; Heyckendorf, J.; Walzl, G.; Lange, C.; Ruhwald, M. Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis. Eur. Respir. J., 2014, 43(5), 1472-1486.
[http://dx.doi.org/10.1183/09031936.00151413] [PMID: 24311770]
[6]
Chee, C.B.; Barkham, T.M.; Khinmar, K.W.; Gan, S.H.; Wang, Y.T. Quantitative T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens in active and latent tuberculosis. Eur. J. Clin. Microbiol. Infect. Dis., 2009, 28(6), 667-670.
[http://dx.doi.org/10.1007/s10096-008-0670-8] [PMID: 19020909]
[7]
Auguste, P.; Tsertsvadze, A.; Pink, J.; Court, R.; McCarthy, N.; Sutcliffe, P.; Clarke, A. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis. BMC Infect. Dis., 2017, 17(1), 200.
[http://dx.doi.org/10.1186/s12879-017-2301-4] [PMID: 28274215]
[8]
Mamishi, S.; Pourakbari, B.; Marjani, M.; Mahmoudi, S. Diagnosis of latent tuberculosis infection among immunodeficient individuals: review of concordance between interferon-gamma release assays and the tuberculin skin test. Br. J. Biomed. Sci., 2014, 71(3), 115-124.
[http://dx.doi.org/10.1080/09674845.2014.11669976] [PMID: 25265757]
[9]
Lu, C.; Wu, J.; Wang, H.; Wang, S.; Diao, N.; Wang, F.; Gao, Y.; Chen, J.; Shao, L.; Weng, X.; Zhang, Y.; Zhang, W. Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells. PLoS One, 2011, 6(8), e24290.
[http://dx.doi.org/10.1371/journal.pone.0024290] [PMID: 21904626]
[10]
Lee, S.W.; Wu, L.S.; Huang, G.M.; Huang, K.Y.; Lee, T.Y.; Weng, J.T. Gene expression profiling identifies candidate biomarkers for active and latent tuberculosis. BMC Bioinformatics, 2016, 17(Suppl. 1), 3.
[http://dx.doi.org/10.1186/s12859-015-0848-x] [PMID: 26818387]
[11]
Youden, W.J. Index for rating diagnostic tests. Cancer, 1950, 3(1), 32-35.
[http://dx.doi.org/10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3] [PMID: 15405679]
[12]
Wallis, R.S.; Pai, M.; Menzies, D.; Doherty, T.M.; Walzl, G.; Perkins, M.D.; Zumla, A. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet, 2010, 375(9729), 1920-1937.
[http://dx.doi.org/10.1016/S0140-6736(10)60359-5] [PMID: 20488517]
[13]
Boisson-Dupuis, S.; Bustamante, J.; El-Baghdadi, J.; Camcioglu, Y.; Parvaneh, N.; El Azbaoui, S.; Agader, A.; Hassani, A.; El Hafidi, N.; Mrani, N.A.; Jouhadi, Z.; Ailal, F.; Najib, J.; Reisli, I.; Zamani, A.; Yosunkaya, S.; Gulle-Girit, S.; Yildiran, A.; Cipe, F.E.; Torun, S.H.; Metin, A.; Atikan, B.Y.; Hatipoglu, N.; Aydogmus, C.; Kilic, S.S.; Dogu, F.; Karaca, N.; Aksu, G.; Kutukculer, N.; Keser-Emiroglu, M.; Somer, A.; Tanir, G.; Aytekin, C.; Adimi, P.; Mahdaviani, S.A.; Mamishi, S.; Bousfiha, A.; Sanal, O.; Mansouri, D.; Casanova, J.L.; Abel, L. Inherited and acquired immunodeficiencies underlying tuberculosis in childhood. Immunol. Rev., 2015, 264(1), 103-120.
[http://dx.doi.org/10.1111/imr.12272] [PMID: 25703555]
[14]
Mamishi, S.; Mahmoudi, S.; Banar, M.; Hosseinpour Sadeghi, R.; Marjani, M.; Pourakbari, B. Diagnostic accuracy of interferon (IFN)-γ inducible protein 10 (IP-10) as a biomarker for the discrimination of active and latent tuberculosis. Mol. Biol. Rep., 2019, 46(6), 6263-6269.
[http://dx.doi.org/10.1007/s11033-019-05067-0] [PMID: 31564016]
[15]
Pai, M.; Minion, J.; Sohn, H.; Zwerling, A.; Perkins, M.D. Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clin. Chest Med., 2009, 30(4), 701-716, viii.
[http://dx.doi.org/10.1016/j.ccm.2009.08.016] [PMID: 19925962]
[16]
Mamishi, S.; Pourakbari, B.; Shams, H.; Marjani, M.; Mahmoudi, S. Improving T-cell assays for diagnosis of latent TB infection: Confirmation of the potential role of testing Interleukin-2 release in Iranian patients. Allergol. Immunopathol. (Madr.), 2016, 44(4), 314-321.
[http://dx.doi.org/10.1016/j.aller.2015.09.004] [PMID: 26786720]
[17]
Mahmoudi, S.; Mamishi, S.; Ghazi, M.; Hosseinpour Sadeghi, R.; Pourakbari, B. Cloning, expression and purification of Mycobacterium tuberculosis ESAT-6 and CFP-10 antigens. Iran. J. Microbiol., 2013, 5(4), 374-378.
[PMID: 25848507]
[18]
Mahmoudi, S.; Pourakbari, B.; Mamishi, S. Interferon Gamma Release Assay in response to PE35/PPE68 proteins: a promising diagnostic method for diagnosis of latent tuberculosis. Eur. Cytokine Netw., 2017, 28(1), 36-40.
[http://dx.doi.org/10.1684/ecn.2017.0391] [PMID: 28840843]
[19]
Mamishi, S.; Pourakbari, B.; Marjani, M.; Bahador, A.; Mahmoudi, S. Discriminating between latent and active tuberculosis: the role of interleukin-2 as biomarker. J. Infect., 2015, 70(4), 429-431.
[http://dx.doi.org/10.1016/j.jinf.2014.12.011] [PMID: 25562449]
[20]
Mamishi, S.; Pourakbari, B.; Teymuri, M.; Rubbo, P.A.; Tuaillon, E.; Keshtkar, A.A.; Mahmoudi, S. Diagnostic accuracy of IL-2 for the diagnosis of latent tuberculosis: a systematic review and meta-analysis. Eur. J. Clin. Microbiol. Infect. Dis., 2014, 33(12), 2111-2119.
[http://dx.doi.org/10.1007/s10096-014-2190-z] [PMID: 24993150]
[21]
Bian, Z-R.; Yin, J.; Sun, W.; Lin, D.J. Microarray and network-based identification of functional modules and pathways of active tuberculosis. Microb. Pathog., 2017, 105, 68-73.
[http://dx.doi.org/10.1016/j.micpath.2017.02.012] [PMID: 28189733]
[22]
Walzl, G.; Ronacher, K.; Hanekom, W.; Scriba, T.J.; Zumla, A. Immunological biomarkers of tuberculosis. Nat. Rev. Immunol., 2011, 11(5), 343-354.
[http://dx.doi.org/10.1038/nri2960] [PMID: 21475309]
[23]
Mihret, A.; Loxton, A.G.; Bekele, Y.; Kaufmann, S.H.; Kidd, M.; Haks, M.C.; Ottenhoff, T.H.; Aseffa, A.; Howe, R.; Walzl, G. Combination of gene expression patterns in whole blood discriminate between tuberculosis infection states. BMC Infect. Dis., 2014, 14, 257.
[http://dx.doi.org/10.1186/1471-2334-14-257] [PMID: 24885723]
[24]
de Araujo, L.S.; Vaas, L.A.; Ribeiro-Alves, M.; Geffers, R.; Mello, F.C.; de Almeida, A.S.; Moreira, A.D.; Kritski, A.L.; Lapa E Silva, J.R.; Moraes, M.O.; Pessler, F.; Saad, M.H. Transcriptomic Biomarkers for Tuberculosis: Evaluation of DOCK9. EPHA4, and NPC2 mRNA Expression in Peripheral Blood. Front. Microbiol., 2016, 7, 1586.
[http://dx.doi.org/10.3389/fmicb.2016.01586] [PMID: 27826286]
[25]
Mamishi, S.; Pourakbari, B.; Sadeghi, R.H.; Marjani, M.; Mahmoudi, S. Diagnostic Accuracy of Monocyte Chemotactic Protein (MCP)-2 as Biomarker in Response to PE35/PPE68 Proteins: A Promising Diagnostic Method for the Discrimination of Active and Latent Tuberculosis. Protein Pept. Lett., 2019, 26(4), 281-286.
[http://dx.doi.org/10.2174/0929866526666190119165805] [PMID: 30663558]
[26]
Chegou, N.N.; Black, G.F.; Kidd, M.; van Helden, P.D.; Walzl, G. Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm. Med., 2009, 9(1), 21.
[http://dx.doi.org/10.1186/1471-2466-9-21] [PMID: 19445695]

Rights & Permissions Print Cite
Article Metrics
16
© 2024 Bentham Science Publishers | Privacy Policy